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looks quite different depending on one’s
perspective. From the aortic or ventricular
side, the AML clearly begins immediately
below the semilunar attachment, whereas
from the atrial side, because of the thick-
ness of the LA itself, the base of the
AML seems to be well below the attach-
ment of the aortic valve cusp. The muscle
of the LA essentially folds down over the
base of the AML.
Again we thank Drs Nezic´, Knezevic´,
and Borovic´ for their interest and welcome
the debate. What could be more fun than
spirited disagreement among colleagues!
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Endovascular treatment of
mycotic aortic aneurysms
To the Editor:
We read with interest the article by Hsu and
Lin1 in which they retrospectively reviewed
their patients who received surgical treat-
ment for infected aortic aneurysms at the aor-
tic arch. Mycotic aortic aneurysm treatment
is a challenging issue. Since the beginning
of modern cardiovascular surgery, surgeons
have searched for better treatment options
because of the high mortality and morbidity
rates of the classic surgical methods. The au-
thors’ results also confirm this.1
With the increasing experience and re-
finements in graft technology, endovascular
grafts are frequently used in the treatment of
aneurysms at critical segments of the aorta,
such as thoracic and arch levels,2 and even
to the ascending aorta by means of hybrid
therapy or alone.3
On the other hand, although it seems com-
pletely opposite to the nature of the treatment
of infected aneurysms, endoluminal stent
grafting is also applied for the treatment of
mycotic aneurysms. Although the long-term
results are not presented, the short and mid-
term outcomes of this treatment modality
have been promising when compared with
conventional surgical techniques (ie, exten-
sive debridement and artificial graft replace-
ment or extra-anatomic bypass procedures).4,5
We believe that endovascular stent graft
repair of mycotic aortic aneurysms, espe-
cially at the critical segments of the aorta
and in debilitated patients, is an attractive al-
ternative option with lowmortality and mor-
bidity rates in the midterm. However, long-
term results are definitely required before
this becomes the standard therapy. It would
be helpful if the authors would have com-
mented on this issue in their article.
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We appreciate Dr Ugurlucan’s comments
on the issue of mycotic aortic aneurysms
treated by endovascular approach. We be-
lieve that the endovascular stent graft is su-
perior in some ways to open surgical repair
for the treatment of mycotic aortic aneu-
rysms, especially in the emergency setting
for debilitated patients with critical aortic
segment involvement. In a recent published
literature review by Kan and colleagues,1
the endovascular treatment strategy was
noted to have 30-day and 2-year survivals
of 89.6% and 82.2%, respectively. To
date, however, there is still no level I evi-
dence to convince us that endovascular
treatment is the criterion standard for my-
cotic aortic aneurysm.
In Taiwan, the abdominal aortic stent
graft was approved by Department of Health
for clinical use only after July 2005, and the
thoracic stent graft was approved after No-
vember 2006. In our published article,2 pa-
tients were treated through 2006, before
the endovascular stent graft era in Taiwan.
Since 2006, we have performed endovascu-
lar stent graft placement in patients with rup-
tured mycotic aortic aneurysm. In our
preliminary data, there have been 4 patients
with ruptured mycotic abdominal and tho-
racic aortic aneurysms treated by the endo-
vascular technique. Of these, 1 patient
required a total visceral artery debranching
procedure for the ruptured suprarenal my-
cotic aneurysm simultaneously with the
stent graft placement. The pathogen is simi-
lar to our published database2 as nontyphoid
Salmonella. There was one in-hospital death
with new development of aortoduodenal fis-
tula. There was another death later than 30
days from the non–aneurysm-related cause
of uncontrolled septic shock. The other 2 pa-
tients require long-term oral antibiotic ther-
apy. There were no cerebral vascular events
or stent graft–related deaths among these 4
patients.
This seems to be a result comparable to
that of open surgical repair. We are still
not sure, however, whether for those with
aortoesophageal aneurysm, aortobronchial
aneurysm, or residual abscess in the image
study further de´bridement and elective
open surgical grafting will be necessary af-
ter stent graft placement, once the patient
condition has been stabilized. In addition,
for mycotic aneurysms involving the aortic
arch or visceral arterial segment, the hybrid
debranching procedure or fenestrated
The advantages of incorporating a hypo-
plastic ventricle to partly support the pulmo-
nary circulation are the following: (1) ability
to increase the cardiac output; (2) adaptation
to exercise; (3) maintenance of pulsatile
flow in the pulmonary circulation; (4) flex-
ibility to increased pulmonary vascular
resistance; (5) circulation at low venous
pressure in the Inferior Vena Cava system;
and (6) capability of a hypoplastic right
heart to adequately handle the reduced
preload.6
There is a major debate for the gray-zone
high-risk patients who do not fulfill the
Choussat commandments. The current pro-
tocol in those patients is first to review all
the data in detail. Full consideration is given
as to whether there are any surgically (or in-
terventionally) correctable lesions, such as
atrioventricular valve regurgitation amena-
ble to repair or isolated stenoses or hypopla-
sia within the central pulmonary arteries.
Ventricular function, if impaired, might be
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Letters to the Editorbranching technique for the stent graft
placement still carries some morbidity and
mortality risk. The optimal use of endovas-
cular stent graft for mycotic aortic aneurysm
needs to be clarified in further studies.
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future Fontan candidates
To the Editor:
We enjoyed the very good article by
Scheurer and colleagues.1 We have a few
comments.
Inhaled nitric oxide produces significant
reduction in Glenn pressures and improve-
ment in systemic perfusion and pulmonary
gas exchange in patients with marked in-
creases of Glenn pressures after bidirec-
tional Glenn anastomosis. Patients who do
not respond should be investigated for an
anatomic lesion.2
Glenn shunt mortality was higher with
surgical intervention before age 120 days
but was not affected by surgical intervention
during the respiratory virus season. Opera-
tions in the youngest age groups might
adversely affect mortality.3
There were no differences in morbidity
and mortality outcomes after the bidirec-
tional Glenn operation between the Nor-
wood-Right ventricle to pulmonary artery
andNorwood-Blalock Taussig Shunt groups.
Despite younger age at presentation, the
Norwood-Right ventricle to pulmonary
artery patients had better growth rate, which
might have contributed to the similar post-
operative outcomes.4
Atrial septal defects should be left open
for all patients with severe right heart hypo-
plasia and in patients with postbypass right
atrial pressures of more than 12 mm Hg.5
optimized by altering medical management
(vasodilators, diuretic therapy, and trial of
oral enoximone, if appropriate). Evidence
of increased pulmonary vascular resistance
is treated with a course of pulmonary vaso-
dilator therapy (sildenafil or bosentan). The
patients are then reassessed for suitability
for Fontan completion. The evidence would
suggest that only 2 of the original 10 com-
mandments of Choussat carry significant
weight for both early and late outcome
over the Fontan procedure and that they
are preoperative ventricular function and
preoperative pulmonary artery pressures of
greater than 15 mm Hg.7
We found that right ventricular mor-
phology; single ventricle; intact septum;
semilunar valve abnormalities; diastolic
dysfunction; myocardial hypertrophy, dila-
tation, or both; older age; bilateral superior
vena cavae; pulmonary airway disease; and
hypotonia all carry a worse prognosis and
a tough postoperative course.
To be right ventricular morphology;
single ventricle; intact septum; semilunar
valve abnormalities; diastolic dysfunction;
myocardial hypertrophy, dilatation, or
both; older age; bilateral superior vena
cavae; Interrupted IVC; pulmonary airway
disease; and hypotonia all carry a worse
prognosis and a tough postoperative
course.
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Hypertension in coarctation
To the Editor:
I read with great interest the article by Hager
and associates1 on coarctation repair. The
authors note that the majority of patients re-
mained hypertensive in the long term, even
after coarctation repair. This very interesting
phenomena, however, has to be examined in
the mirror of the little known fact that most
patients are often hypertensive below the
level of the coarctation even before the
coarctation is repaired! While pressure
measurements indeed show significantly
higher pressures above the coarctation, the
mean arterial pressure below the coarcta-
tion is also higher than that of an average
normal subject. Thus, arterial hypertension
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